Status:
UNKNOWN
Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist
Lead Sponsor:
Guy's Hospital
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Magnetic Resonance Imaging (MRI) is an effective and radiation free method of diagnosing Congenital Heart Disease (CHD). MRI works by taking images of the anatomy and physiology. These images also pro...
Detailed Description
We planned an intra-individual study, where 20 adult patients with CHD (e.g. Fallot Tetralogy, s/p corrective surgery, single ventricle s/p Fontan operation, aortic and pulmonary artery stenosis) will...
Eligibility Criteria
Inclusion
- The main inclusion criteria will be patient with CHD, i.e. complex congenital defects such as:
- Aortic abnormalities
- Pulmonary artery abnormalities
- Systemic or pulmonary venous abnormalities
- The study will be limited to patients aged 18 and over
Exclusion
- The study will involve MR contrast agents and and MRI scans, therefore the principle exclusion criteria are:
- Any contra-indications to MR (e.g. pacemakers)
- Known allergy to MR contrast agents
- Patients not agreeing to take part in study
- Pregnancy and nursing mothers
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
December 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00668824
Start Date
March 1 2007
End Date
December 1 2009
Last Update
August 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Imaging Sciences
London, United Kingdom, SE1 7EH